Why is Emcure Pharma falling/rising?

As of 08-Jul, Emcure Pharmaceuticals Ltd is experiencing a decline in its stock price, currently at 1,243.00, reflecting a decrease of 3.15 points or 0.25%. The stock has been on a downward trend, having fallen for the last three consecutive days, resulting in a total decline of 2.98% during this period. Additionally, the stock has underperformed significantly over the past week and month, with returns of -3.15% and -6.50%, respectively. Despite showing strong management efficiency and positive quarterly results, including record net sales and profitability, the stock faces challenges due to poor long-term growth prospects and an expensive valuation relative to its returns.
In the broader market context, the Sensex has shown a slight increase of 0.02% over the past week and a more substantial gain of 1.85% over the past month, indicating that the overall market is performing better than Emcure Pharmaceuticals. The stock's recent performance has been hindered by a significant drop in investor participation, with delivery volume plummeting by 91.49% compared to the five-day average, suggesting reduced interest among investors. This lack of engagement, combined with the company's high valuation metrics and modest growth in operating profit, contributes to the stock's current downward trajectory.